Ipca Laboratories Ltd
Nifty 500
Midcap 150
LargeMid 250
₹1,968.50
-0.12%
Delayed · cached 15 min
Fair value analysis
IPCALAB
Ipca Laboratories Ltd
₹1,970.90
Close used for this calculation
₹1,398.76Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
58/100
Quality radar
Consensus fair value
₹1,398.76
Above FV▼ -29.0% against the close used
Model range ₹380.69 – ₹2,025.71
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹380.69Fair value₹1,398.76Bull₹2,025.71
FairClose
52-week traded range
52W low ₹1,268.7052W high ₹1,987.60
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Ipca Laboratories Ltd closed at ₹1,970.90, 40.9% above the consensus fair value of ₹1,398.76 drawn from 9 valuation models.
Financial DNA score 58/100 — Good. P/E of 36.4x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹380.69
-80.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹622.34
-68.4%
√(22.5 × EPS × BVPS)
EPS=44.98, BVPS=382.7 · outside Graham range (P/E 36.4, P/B 5.2) — asset-light, treat as a rough floor
Graham Formula
₹2,025.71
+2.8%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹1,605.79
-18.5%
EPS × 35.7x (sector P/E)
EPS=44.98, Sector P/E=35.7x
Peter Lynch (PEG)
₹1,124.50
-42.9%
EPS × Growth% (PEG = 1 is fair)
EPS=44.98, g=25%
EV/EBITDA
₹1,678.59
-14.8%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=24.08B
Book Value (P/B)
₹928.05
-52.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=382.7, ROE=15.7%, g=6%, r=10%
Reverse DCF
₹1,970.90
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 17.7% | Historical: 25%
Margin of Safety
₹868.97
-55.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=1158.63, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.